Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.

Identifieur interne : 000563 ( Main/Exploration ); précédent : 000562; suivant : 000564

Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.

Auteurs : Matthew P. Sullivan [Nouvelle-Zélande] ; Stuart J. Morrow [Nouvelle-Zélande] ; David C. Goldstone [Nouvelle-Zélande] ; Christian G. Hartinger [Nouvelle-Zélande]

Source :

RBID : pubmed:31087392

Descripteurs français

English descriptors

Abstract

Cisplatin and its second and third generation analogues are widely used in the treatment of cancer. To study their reactions with proteins, we present a method based on SDS-PAGE separation and laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) for platinum detection in the reaction between human serum albumin (HSA) and cisplatin. We developed matrix-matched standards of HSA/cisplatin mixtures and used them to quantify the amount of adducts formed at different HSA:cisplatin ratios. We noted that cisplatin incubation with HSA resulted in the formation of higher order HSA n-mers, depending on the amount of cisplatin added. This caused a depletion of the HSA dimer bands, while the majority of HSA was present as the monomer. Inducing the formation of such higher molecular weight species may have an impact on the mode of action of metallodrugs.

DOI: 10.1002/elps.201900070
PubMed: 31087392


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.</title>
<author>
<name sortKey="Sullivan, Matthew P" sort="Sullivan, Matthew P" uniqKey="Sullivan M" first="Matthew P" last="Sullivan">Matthew P. Sullivan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morrow, Stuart J" sort="Morrow, Stuart J" uniqKey="Morrow S" first="Stuart J" last="Morrow">Stuart J. Morrow</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Goldstone, David C" sort="Goldstone, David C" uniqKey="Goldstone D" first="David C" last="Goldstone">David C. Goldstone</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biological Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Biological Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hartinger, Christian G" sort="Hartinger, Christian G" uniqKey="Hartinger C" first="Christian G" last="Hartinger">Christian G. Hartinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31087392</idno>
<idno type="pmid">31087392</idno>
<idno type="doi">10.1002/elps.201900070</idno>
<idno type="wicri:Area/PubMed/Corpus">000540</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000540</idno>
<idno type="wicri:Area/PubMed/Curation">000540</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000540</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000550</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000550</idno>
<idno type="wicri:Area/Ncbi/Merge">002217</idno>
<idno type="wicri:Area/Ncbi/Curation">002217</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002217</idno>
<idno type="wicri:Area/Main/Merge">000566</idno>
<idno type="wicri:Area/Main/Curation">000563</idno>
<idno type="wicri:Area/Main/Exploration">000563</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.</title>
<author>
<name sortKey="Sullivan, Matthew P" sort="Sullivan, Matthew P" uniqKey="Sullivan M" first="Matthew P" last="Sullivan">Matthew P. Sullivan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morrow, Stuart J" sort="Morrow, Stuart J" uniqKey="Morrow S" first="Stuart J" last="Morrow">Stuart J. Morrow</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Goldstone, David C" sort="Goldstone, David C" uniqKey="Goldstone D" first="David C" last="Goldstone">David C. Goldstone</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biological Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Biological Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hartinger, Christian G" sort="Hartinger, Christian G" uniqKey="Hartinger C" first="Christian G" last="Hartinger">Christian G. Hartinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemical Sciences, University of Auckland, Auckland, New Zealand.</nlm:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>School of Chemical Sciences, University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Electrophoresis</title>
<idno type="eISSN">1522-2683</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antineoplastic Agents (analysis)</term>
<term>Antineoplastic Agents (chemistry)</term>
<term>Antineoplastic Agents (metabolism)</term>
<term>Cisplatin (analysis)</term>
<term>Cisplatin (chemistry)</term>
<term>Cisplatin (metabolism)</term>
<term>Humans</term>
<term>Lasers</term>
<term>Mass Spectrometry (methods)</term>
<term>Serum Albumin, Human (chemistry)</term>
<term>Serum Albumin, Human (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antinéoplasiques ()</term>
<term>Antinéoplasiques (analyse)</term>
<term>Antinéoplasiques (métabolisme)</term>
<term>Cisplatine ()</term>
<term>Cisplatine (analyse)</term>
<term>Cisplatine (métabolisme)</term>
<term>Humains</term>
<term>Lasers</term>
<term>Spectrométrie de masse ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Cisplatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Cisplatin</term>
<term>Serum Albumin, Human</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Antineoplastic Agents</term>
<term>Cisplatin</term>
<term>Serum Albumin, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Cisplatine</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Mass Spectrometry</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Cisplatine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Lasers</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Antinéoplasiques</term>
<term>Cisplatine</term>
<term>Humains</term>
<term>Lasers</term>
<term>Spectrométrie de masse</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cisplatin and its second and third generation analogues are widely used in the treatment of cancer. To study their reactions with proteins, we present a method based on SDS-PAGE separation and laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) for platinum detection in the reaction between human serum albumin (HSA) and cisplatin. We developed matrix-matched standards of HSA/cisplatin mixtures and used them to quantify the amount of adducts formed at different HSA:cisplatin ratios. We noted that cisplatin incubation with HSA resulted in the formation of higher order HSA n-mers, depending on the amount of cisplatin added. This caused a depletion of the HSA dimer bands, while the majority of HSA was present as the monomer. Inducing the formation of such higher molecular weight species may have an impact on the mode of action of metallodrugs.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Nouvelle-Zélande</li>
</country>
</list>
<tree>
<country name="Nouvelle-Zélande">
<noRegion>
<name sortKey="Sullivan, Matthew P" sort="Sullivan, Matthew P" uniqKey="Sullivan M" first="Matthew P" last="Sullivan">Matthew P. Sullivan</name>
</noRegion>
<name sortKey="Goldstone, David C" sort="Goldstone, David C" uniqKey="Goldstone D" first="David C" last="Goldstone">David C. Goldstone</name>
<name sortKey="Hartinger, Christian G" sort="Hartinger, Christian G" uniqKey="Hartinger C" first="Christian G" last="Hartinger">Christian G. Hartinger</name>
<name sortKey="Morrow, Stuart J" sort="Morrow, Stuart J" uniqKey="Morrow S" first="Stuart J" last="Morrow">Stuart J. Morrow</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000563 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000563 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31087392
   |texte=   Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31087392" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021